Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1996;79:974-983

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pietruck, F.
Right arrow Articles by Siffert, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pietruck, F.
Right arrow Articles by Siffert, W.
(Circulation Research. 1996;79:974-983.)
© 1996 American Heart Association, Inc.


Articles

Selectively Enhanced Cellular Signaling by Gi Proteins in Essential Hypertension

G{alpha}i2, G{alpha}i3, Gß1, and Gß2 Are Not Mutated

Frank Pietruck, Albrecht Moritz, Michael Montemurro, Alexandra Sell, Stefan Busch, Dieter Rosskopf, Sebastian Virchow, Helmut Esche, Norbert Brockmeyer, Karl H. Jakobs, Winfried Siffert

the Institut fur Pharmakologie (F.P., A.M., A.S., S.B., D.R., S.V., K.H.J., W.S.), the Abteilung fur Kardiologie (M.M.), the Institut fur Molekularbiologie (H.E.), and the Hautklinik (N.B.), Universitatsklinikum Essen (Germany).

Correspondence to Dr Winfried Siffert, Institut fur Pharmakologie, Universitatsklinikum Essen, Hufelandstrasse 55, D-45122 Essen, Germany.

Recent studies have shown an enhanced signaling capacity of receptors coupled to pertussis toxin (PTX)–sensitive guanine nucleotide–binding proteins (G proteins) in immortalized B lymphoblasts from patients with essential hypertension. In the present study, we analyzed (1) whether such alterations would also be expressed in nontransformed cells of these individuals and (2) whether other G protein–mediated signaling pathways were also altered. Therefore, we established primary cultures of skin fibroblasts from previously characterized normotensive and hypertensive individuals (NT and HT cells, respectively). [Ca2+]i rises induced by lyso-phosphatidic acid (LPA), thrombin, and sphingosine-1-phosphate as well as the formation of inositol 1,4,5-trisphosphate and [3H]thymidine incorporation evoked by LPA were PTX sensitive and enhanced twofold in HT fibroblasts. In contrast, cellular responses induced by bradykinin, endothelin-1, and angiotensin II (all PTX insensitive) were similar in NT and HT cells. Formation of cAMP induced by stimulation of Gs with isoproterenol was identical in NT and HT cells. Western blot analysis yielded no evidence for an overexpression of G{alpha}i2, G{alpha}i3, Gß2, and Gß4. Furthermore, sequencing of cDNAs encoding for the ubiquitously expressed PTX-sensitive G protein subunits G{alpha}i2, G{alpha}i3, Gß1, and Gß2 from NT and HT cell lines yielded no evidence for mutations in these genes. Although the molecular mechanisms remain to be defined, these data support the concept of a selective enhancement of signal transduction via PTX-sensitive G proteins in essential hypertension.


Key Words: fibroblasts • lyso-phosphatidic acid • bradykinin • platelet-derived growth factor • proliferation




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
N. Wettschureck and S. Offermanns
Mammalian G Proteins and Their Cell Type Specific Functions
Physiol Rev, October 1, 2005; 85(4): 1159 - 1204.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. K. Brar, A. Chen, M. H. Perrin, and W. Vale
Specificity and Regulation of Extracellularly Regulated Kinase1/2 Phosphorylation through Corticotropin-Releasing Factor (CRF) Receptors 1 and 2{beta} by the CRF/Urocortin Family of Peptides
Endocrinology, April 1, 2004; 145(4): 1718 - 1729.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Izawa, Y. Yamada, T. Okada, M. Tanaka, H. Hirayama, and M. Yokota
Prediction of Genetic Risk for Hypertension
Hypertension, May 1, 2003; 41(5): 1035 - 1040.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
W. Siffert
Effects of the G protein {beta}3-subunit gene C825T polymorphism: should hypotheses regarding the molecular mechanisms underlying enhanced G protein activation be revised? Focus on "A splice variant of the G protein {beta}3-subunit implicated in disease states does not modulate ion channels"
Physiol Genomics, April 16, 2003; 13(2): 81 - 84.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Heusch, R. Erbel, and W. Siffert
Genetic determinants of coronary vasomotor tone in humans
Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1465 - H1468.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Okumura, T. Osanai, T. Kosugi, H. Hanada, H. Ishizaka, T. Fukushi, T. Kamada, T. Miura, T. Hatayama, T. Nakano, et al.
Enhanced phospholipase C activity in the cultured skin fibroblast obtained from patients with coronary spastic angina: possible role for enhanced vasoconstrictor response
J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1847 - 1852.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
W. Siffert
G protein {beta}3 subunit 825T allele, hypertension, obesity, and diabetic nephropathy
Nephrol. Dial. Transplant., September 1, 2000; 15(9): 1298 - 1306.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
W. SIFFERT, P. FORSTER, K.-H. JÖCKEL, D. A. MVERE, B. BRINKMANN, C. NABER, R. CROOKES, A. D. P. HEYNS, J. T. EPPLEN, J. FRIDEY, et al.
Worldwide Ethnic Distribution of the G Protein {beta}3 Subunit 825T Allele and Its Association with Obesity in Caucasian, Chinese, and Black African Individuals
J. Am. Soc. Nephrol., September 1, 1999; 10(9): 1921 - 1930.
[Abstract] [Full Text]


Home page
HypertensionHome page
E. Brand, S.-M. Herrmann, V. Nicaud, J.-B. Ruidavets, A. Evans, D. Arveiler, G. Luc, P.-F. Plouin, L. Tiret, and F. Cambien
The 825C/T Polymorphism of the G-Protein Subunit ß3 Is Not Related to Hypertension
Hypertension, May 1, 1999; 33(5): 1175 - 1178.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. V. Benjafield, C. L. Jeyasingam, D. R. Nyholt, L. R. Griffiths, and B. J. Morris
G-Protein ß3 Subunit Gene (GNB3) Variant in Causation of Essential Hypertension
Hypertension, December 1, 1998; 32(6): 1094 - 1097.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. A. Hegele, S. B. Harris, A. J. G. Hanley, H. Cao, and B. Zinman
G Protein ß3 Subunit Gene Variant and Blood Pressure Variation in Canadian Oji-Cree
Hypertension, October 1, 1998; 32(4): 688 - 692.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Schunkert, H.-W. Hense, A. Doring, G. A. J. Riegger, and W. Siffert
Association Between a Polymorphism in the G Protein ß3 Subunit Gene and Lower Renin and Elevated Diastolic Blood Pressure Levels
Hypertension, September 1, 1998; 32(3): 510 - 513.
[Abstract] [Full Text] [PDF]